tiprankstipranks
Cardiff Oncology, Inc. (CRDF)
NASDAQ:CRDF

Cardiff Oncology (CRDF) Similar Stocks

Compare
1,676 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Cardiff Oncology
$3.44
$228.84M
-36.18%
5 Buy
0 Hold
0 Sell
Strong Buy
Exelixis
$36.84
$10.55B
20.88
56.04%
10 Buy
7 Hold
0 Sell
Moderate Buy
Gilead Sciences
$111.16
$138.43B
285.67
57.45%
17 Buy
6 Hold
0 Sell
Moderate Buy
Karyopharm Therapeutics
$4.35
$47.13M
-80.79%
5 Buy
1 Hold
0 Sell
Strong Buy
TG Therapeutics
$40.20
$6.41B
292.19
160.36%
5 Buy
0 Hold
1 Sell
Moderate Buy
Blueprint Medicines
$89.73
$5.95B
-5.41%
14 Buy
4 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CRDF
Cardiff Oncology
3.44
-1.90
-35.58%
EXEL
Exelixis
36.84
13.11
55.25%
GILD
Gilead Sciences
111.16
40.56
57.45%
KPTI
Karyopharm Therapeutics
4.35
-18.30
-80.79%
TGTX
TG Therapeutics
40.20
24.99
164.30%
BPMC
Blueprint Medicines
89.73
-5.13
-5.41%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis